AngioScore, Inc. Announces Successful Initiation of Enrollment in Drug-Coated AngioSculpt® Scoring Balloon Catheter First-in-Human Study
FREMONT, Calif.--(BUSINESS WIRE)--AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the successful initiation of enrollment in the Drug-Coated AngioSculpt Scoring Balloon Catheter First-in-Human (FIH) Study.